Júnia de Oliveira Costa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Júnia de Oliveira Costa has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Edigar Henrique Vaz Dias
Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil
5 shared publications - Nilson Penha-Silva
Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, MG, Brazil
5 shared publications - Fábio de Oliveira
Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil; Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica (N-Biofar), Belo Horizonte, MG, Brazil
4 shared publications - Andreimar Martins Soares
Laboratory of Biotechnology of Proteins and Bioactive Compounds Applied to Health, - Fundação Oswaldo Cruz, Fiocruz, Fiocruz Rondônia, Porto Velho, RO, Brazil
3 shared publications Bruna Barbosa de Sousa
Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil
3 shared publicationsCarla Cristine Neves Mamede
Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica (N-Biofar), Belo Horizonte, MG, Brazil
3 shared publications
Latest Publications
- 1 April 2026
- Published by Universidade Federal de Goias in Revista de Patologia Tropical / Journal of Tropical Pathology
- Vol. 55 (1) , 1-16
Epidemiology of snakebites in the Catalão microregion, Goiás, Brazil
Snakebites represent a major public health problem, especially in tropical countries such as Brazil. This study analyzed the epidemiology of snakebites in the geographical microregion of Catalão, Goiás, from 2017 to 2023. This is a descriptive, quantitative, and retrospective analysis based on data collection from the Ministry of Health's Notifiable Diseases Information System (SINAN). A total of 273 cases of snakebites were reported, 62.27% of which were bothropic. There was a greater incidence of males (81.32%) and those aged between 40 and 59 years (39.93%). It is noteworthy that 75% of the accidents were non-occupational. Approximately half of the cases were classified as mild (50.43%). The anatomical region of the foot and leg was the most affected. Most victims received medical care within 3 hours (89.07%), underwent serum therapy (89.22%) and were cured. The municipality of Três Ranchos had the highest incidence of cases (513.52/100.000 inhabitants), while Catalão had the highest annual average (17.4) and the highest percentage of occurrence (35.8%). The epidemiological study of snakebite accidents contributes to understanding the impact of this disease on the population and provides data for the development of health surveillance, awareness and prevention measures in the region.
- 1 April 2026
- Published by Universidade Federal de Goias in Revista de Patologia Tropical / Journal of Tropical Pathology
- Vol. 55 (1) , 1-16
Epidemiology of snakebites in the Catalão microregion, Goiás, Brazil
Snakebites represent a major public health problem, especially in tropical countries such as Brazil. This study analyzed the epidemiology of snakebites in the geographical microregion of Catalão, Goiás, from 2017 to 2023. This is a descriptive, quantitative, and retrospective analysis based on data collection from the Ministry of Health's Notifiable Diseases Information System (SINAN). A total of 273 cases of snakebites were reported, 62.27% of which were bothropic. There was a greater incidence of males (81.32%) and those aged between 40 and 59 years (39.93%). It is noteworthy that 75% of the accidents were non-occupational. Approximately half of the cases were classified as mild (50.43%). The anatomical region of the foot and leg was the most affected. Most victims received medical care within 3 hours (89.07%), underwent serum therapy (89.22%) and were cured. The municipality of Três Ranchos had the highest incidence of cases (513.52/100.000 inhabitants), while Catalão had the highest annual average (17.4) and the highest percentage of occurrence (35.8%). The epidemiological study of snakebite accidents contributes to understanding the impact of this disease on the population and provides data for the development of health surveillance, awareness and prevention measures in the region.
- Open Access
- 26 February 2024
- Published by Sociedade Brasileira de Cardiologia in International Journal of Cardiovascular Sciences
- Vol. 37
Bothrops Moojeni Snake Venom: A Source of Potential Therapeutic Agents Against Hemostatic Disorders
Hemostasis is a complex set of biological processes responsible for blood fluidity within normal vessels and for the physiological interruption of bleeding in cases of vascular injury. Bothrops moojeni snake venom is rich in bioactive compounds of pharmacological and clinical interest since its protein components are capable of interfering with many points of the hemostatic process. Here, we present the B. moojeni venom proteins that affect hemostasis and discuss their pharmacological and clinical potential. This systematic review was conducted [...] Abstract Hemostasis is a complex set of biological processes responsible for blood fluidity within normal vessels and for the physiological interruption of bleeding in cases of vascular injury. Bothrops moojeni snake venom is rich in bioactive compounds of pharmacological and clinical interest since its protein components are capable of interfering with many points of the hemostatic process. Here, we present the B. moojeni venom proteins that affect hemostasis and discuss their pharmacological and clinical potential. This systematic review was conducted
- 26 February 2024
- Published by Sociedade Brasileira de Cardiologia in International Journal of Cardiovascular Sciences
- Vol. 37
Open AccessBothrops Moojeni Snake Venom: A Source of Potential Therapeutic Agents Against Hemostatic Disorders
Hemostasis is a complex set of biological processes responsible for blood fluidity within normal vessels and for the physiological interruption of bleeding in cases of vascular injury. Bothrops moojeni snake venom is rich in bioactive compounds of pharmacological and clinical interest since its protein components are capable of interfering with many points of the hemostatic process. Here, we present the B. moojeni venom proteins that affect hemostasis and discuss their pharmacological and clinical potential. This systematic review was conducted [...] Abstract Hemostasis is a complex set of biological processes responsible for blood fluidity within normal vessels and for the physiological interruption of bleeding in cases of vascular injury. Bothrops moojeni snake venom is rich in bioactive compounds of pharmacological and clinical interest since its protein components are capable of interfering with many points of the hemostatic process. Here, we present the B. moojeni venom proteins that affect hemostasis and discuss their pharmacological and clinical potential. This systematic review was conducted
- 1 October 2018
- Published by Wiley in International Journal of Experimental Pathology
- Vol. 99 (5) , 226-235
Systemic alterations induced by phospholipase A2, BmooTX‐I, isolated from Bothrops moojeni snake venom
Summary: Ophidic accidents are among the problems of public health in Brazil. The components from bothropic venom are responsible for many systemic clinical complications resulting from envenomation. The present work aimed to analyse the systemic changes induced in mice after intraperitoneal administration of BmooTX‐I, a myotoxic acidic phospholipase A2 isolated from Bothrops moojeni venom. Urinalysis was performed and the following plasma biochemical markers were documented: urea, creatinine and uric acid (renal function); glucose and amylase (pancreatic function); alanine aminotransferase, alkaline phosphatase and gamma‐GT (intra‐ and extrahepatic function); creatine kinase and enzymatic lactate (muscle function). Our results showed that after the intraperitoneal injection of BmooTX‐I the urine of these animals showed glycosuria, proteinuria, haematuria, bacteriuria, bilirubinuria, polyuria and nitrite. The plasma biochemical analysis showed alterations in levels of urea, creatinine and uric acid. Amylase concentration was not altered significantly, but the plasma glucose increased significantly compared to controls. The plasma levels of alanine aminotransferase and alkaline phosphatase decreased and increased, respectively, in these same animals. On the other hand, the plasma γGT concentration did not undergo significant modification compared to the control group. The plasma concentration of CK increased, while the enzymatic lactate concentration decreased after the injection of the BmooTX‐I. Therefore, in mice BmooTX‐I is capable of causing systemic alterations which manifest as renal, muscular, hepatic and pancreatic impairment.
- 1 October 2018
- Published by Wiley in International Journal of Experimental Pathology
- Vol. 99 (5) , 226-235
Systemic alterations induced by phospholipase A2, BmooTX‐I, isolated from Bothrops moojeni snake venom
Summary: Ophidic accidents are among the problems of public health in Brazil. The components from bothropic venom are responsible for many systemic clinical complications resulting from envenomation. The present work aimed to analyse the systemic changes induced in mice after intraperitoneal administration of BmooTX‐I, a myotoxic acidic phospholipase A2 isolated from Bothrops moojeni venom. Urinalysis was performed and the following plasma biochemical markers were documented: urea, creatinine and uric acid (renal function); glucose and amylase (pancreatic function); alanine aminotransferase, alkaline phosphatase and gamma‐GT (intra‐ and extrahepatic function); creatine kinase and enzymatic lactate (muscle function). Our results showed that after the intraperitoneal injection of BmooTX‐I the urine of these animals showed glycosuria, proteinuria, haematuria, bacteriuria, bilirubinuria, polyuria and nitrite. The plasma biochemical analysis showed alterations in levels of urea, creatinine and uric acid. Amylase concentration was not altered significantly, but the plasma glucose increased significantly compared to controls. The plasma levels of alanine aminotransferase and alkaline phosphatase decreased and increased, respectively, in these same animals. On the other hand, the plasma γGT concentration did not undergo significant modification compared to the control group. The plasma concentration of CK increased, while the enzymatic lactate concentration decreased after the injection of the BmooTX‐I. Therefore, in mice BmooTX‐I is capable of causing systemic alterations which manifest as renal, muscular, hepatic and pancreatic impairment.
- Open Access
- 1 November 2017
- Published by Wiley in BioMed Research International
- Vol. 2017, 1-9
A New Platelet-Aggregation-Inhibiting Factor Isolated fromBothrops moojeniSnake Venom
This work reports the purification and functional characterization of BmooPAi, a platelet-aggregation-inhibiting factor fromBothrops moojenisnake venom. The toxin was purified by a combination of three chromatographic steps (ion-exchange on DEAE-Sephacel, molecular exclusion on Sephadex G-75, and affinity chromatography on HiTrap™ Heparin HP). BmooPAi was found to be a single-chain protein with an apparent molecular mass of 32 kDa on 14% SDS-PAGE, under reducing conditions. Sequencing of BmooPAi by Edman degradation revealed the amino acid sequence LGPDIVPPNELLEVM. The toxin was devoid of proteolytic, haemorrhagic, defibrinating, or coagulant activities and induced no significant oedema or hyperalgesia. BmooPAi showed a rather specific inhibitory effect on ristocetin-induced platelet aggregation in human platelet-rich plasma, whereas it had little or no effect on platelet aggregation induced by collagen and adenosine diphosphate. The results presented in this work suggest that BmooPAi is a toxin comprised of disintegrin-like and cysteine-rich domains, originating from autolysis/proteolysis of PIII SVMPs fromB. moojenisnake venom. This toxin may be of medical interest because it is a platelet aggregation inhibitor, which could potentially be developed as a novel therapeutic agent to prevent and/or treat patients with thrombotic disorders.
- 1 November 2017
- Published by Wiley in BioMed Research International
- Vol. 2017, 1-9
Open AccessA New Platelet-Aggregation-Inhibiting Factor Isolated fromBothrops moojeniSnake Venom
This work reports the purification and functional characterization of BmooPAi, a platelet-aggregation-inhibiting factor fromBothrops moojenisnake venom. The toxin was purified by a combination of three chromatographic steps (ion-exchange on DEAE-Sephacel, molecular exclusion on Sephadex G-75, and affinity chromatography on HiTrap™ Heparin HP). BmooPAi was found to be a single-chain protein with an apparent molecular mass of 32 kDa on 14% SDS-PAGE, under reducing conditions. Sequencing of BmooPAi by Edman degradation revealed the amino acid sequence LGPDIVPPNELLEVM. The toxin was devoid of proteolytic, haemorrhagic, defibrinating, or coagulant activities and induced no significant oedema or hyperalgesia. BmooPAi showed a rather specific inhibitory effect on ristocetin-induced platelet aggregation in human platelet-rich plasma, whereas it had little or no effect on platelet aggregation induced by collagen and adenosine diphosphate. The results presented in this work suggest that BmooPAi is a toxin comprised of disintegrin-like and cysteine-rich domains, originating from autolysis/proteolysis of PIII SVMPs fromB. moojenisnake venom. This toxin may be of medical interest because it is a platelet aggregation inhibitor, which could potentially be developed as a novel therapeutic agent to prevent and/or treat patients with thrombotic disorders.
- Open Access
- 28 July 2017
- Published by Springer Nature in Journal of Venomous Animals and Toxins including Tropical Diseases
- Vol. 23 (1) , 1-8
BaltDC: purification, characterization and infrared spectroscopy of an antiplatelet DC protein isolated from Bothrops alternatus snake venom
Snake venoms are a complex mixture of proteins, organic and inorganic compounds. Some of these proteins, enzymatic or non-enzymatic ones, are able to interact with platelet receptors, causing hemostatic disorders. The possible therapeutic potential of toxins with antiplatelet properties may arouse interest in the pharmacological areas. The present study aimed to purify and characterize an antiplatelet DC protein from Bothrops alternatus snake venom. The protein, called BaltDC (DC protein from B. alternatus snake venom), was purified by a combination of ion-exchange chromatography on DEAE-Sephacel column and gel filtration on Sephadex G-75. The molecular mass was estimated by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate (SDS-PAGE). The amino acid sequence of the N-terminal region was carried out by Edman degradation method. Platelet aggregation assays were performed in human platelet-rich plasma (PRP). Infrared (IR) spectroscopy was used in order to elucidate the interactions between BaltDC and platelet membrane. BaltDC ran as a single protein band on SDS-PAGE and showed apparent molecular mass of 32 kDa under reducing or non-reducing conditions. The N-terminal region of the purified protein revealed the amino acid sequence IISPPVCGNELLEVGEECDCGTPENCQNECCDA, which showed identity with other snake venom metalloproteinases (SVMPs). BaltDC was devoid of proteolytic, hemorrhagic, defibrinating or coagulant activities, but it showed a specific inhibitory effect on platelet aggregation induced by ristocetin and epinephrine in PRP. IR analysis spectra strongly suggests that PO3 2− groups, present in BaltDC, form hydrogen bonds with the PO2 − groups present in the non-lipid portion of the membrane platelets. BaltDC may be of medical interest since it was able to inhibit platelet aggregation.
- 28 July 2017
- Published by Springer Nature in Journal of Venomous Animals and Toxins including Tropical Diseases
- Vol. 23 (1) , 1-8
Open AccessBaltDC: purification, characterization and infrared spectroscopy of an antiplatelet DC protein isolated from Bothrops alternatus snake venom
Snake venoms are a complex mixture of proteins, organic and inorganic compounds. Some of these proteins, enzymatic or non-enzymatic ones, are able to interact with platelet receptors, causing hemostatic disorders. The possible therapeutic potential of toxins with antiplatelet properties may arouse interest in the pharmacological areas. The present study aimed to purify and characterize an antiplatelet DC protein from Bothrops alternatus snake venom. The protein, called BaltDC (DC protein from B. alternatus snake venom), was purified by a combination of ion-exchange chromatography on DEAE-Sephacel column and gel filtration on Sephadex G-75. The molecular mass was estimated by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate (SDS-PAGE). The amino acid sequence of the N-terminal region was carried out by Edman degradation method. Platelet aggregation assays were performed in human platelet-rich plasma (PRP). Infrared (IR) spectroscopy was used in order to elucidate the interactions between BaltDC and platelet membrane. BaltDC ran as a single protein band on SDS-PAGE and showed apparent molecular mass of 32 kDa under reducing or non-reducing conditions. The N-terminal region of the purified protein revealed the amino acid sequence IISPPVCGNELLEVGEECDCGTPENCQNECCDA, which showed identity with other snake venom metalloproteinases (SVMPs). BaltDC was devoid of proteolytic, hemorrhagic, defibrinating or coagulant activities, but it showed a specific inhibitory effect on platelet aggregation induced by ristocetin and epinephrine in PRP. IR analysis spectra strongly suggests that PO3 2− groups, present in BaltDC, form hydrogen bonds with the PO2 − groups present in the non-lipid portion of the membrane platelets. BaltDC may be of medical interest since it was able to inhibit platelet aggregation.
- 1 May 2010
- Published by Elsevier in Phytochemistry
- Vol. 71 (7) , 708-715
Purification and biochemical characterization of Eumiliin from Euphorbia milii var. hislopii latex
- 1 May 2010
- Published by Elsevier in Phytochemistry
- Vol. 71 (7) , 708-715
Purification and biochemical characterization of Eumiliin from Euphorbia milii var. hislopii latex